Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
NEP / NextEra Energy Partners LP S-3

2018-07-05 sec.gov
S-3 Table of Contents As filed with the Securities and Exchange Commission on July 3, 2018 Registration Statement No. 333-
NEP

0
NEP / NextEra Energy Partners LP S-3ASR

2018-07-05 sec.gov
S-3ASR Table of Contents As filed with the Securities and Exchange Commission on July 3, 2018 Registration Statement No. 333-
NEP

0
NEP / NextEra Energy Partners LP S-3

2018-07-03 sec.gov
S-3 Table of Contents As filed with the Securities and Exchange Commission on July 3, 2018 Registration Statement No. 333- <
NEP

0
NextEra Energy Partners (NEP) Presents At J.P. Morgan Energy Equity Conference - Slideshow

2018-06-20 seekingalpha
The following slide deck was published by NextEra Energy Partners, LP in conjunction with this event.
NEP

0
Azure Power price target lifted to $24 from $22 at Credit Suisse

2018-06-18 marketwatch
Zacks Industry Outlook Highlights: Jinko Solar, Azure Power Global, Dominion Midstream, SunPower and NextEra Energy Partners
AZRE NEP

28
FuelCell Energy (FCEL) Q2 Loss Wider Than Expected, Sales Top

2018-06-08 zacks
FuelCell Energy, Inc. (FCEL - Free Report) incurred second-quarter fiscal 2018 adjusted loss of 23 cents per share, wider than the Zacks Consensus Estimate of a loss of 17 cents. However, the company’s loss was narrower than 33 cents recorded in the year-ago period. Total Revenues During the quarter under review, FuelCell Energy reported adjusted revenues of $20.8 million, surpassing the Zacks Consensus Estimate of $20 million by 4.
GEVO UNP FCELB NEP CVA FCEL

10
Update On My 'Sell The Oils' Thesis: Will The Sell-Off Continue?

2018-06-07 seekingalpha
The Iran sanctions made my oil-bearish April call wrong initially, but as of Tuesday, it is looking better.
NEE.PRI DRQ NEE.PRJ HP XOM NEE.PRC NEE.PRQ NEE.PRR NEP TRN NEE

36
Utilities: Timely? Sector Comments Plus 3 Stocks To Consider

2018-05-28 seekingalpha
Given no recession and large Federal deficits, sticking with stocks for alpha over bonds makes sense.
SOJA SO DUKH AEP.PRA DUK NEP NEE.PRI NEE.PRJ NEE.PRC NEE.PRQ AEP NEE.PRR NEE

7
NextEra Energy (NEE) Down 1.7% Since Earnings Report: Can It Rebound?

2018-05-25 zacks
It has been about a month since the last earnings report for NextEra Energy, Inc. (NEE - Free Report) . Shares have lost about 1.7% in that time frame.
NEE.PRI NEE.PRJ WYNN NEE.PRC NEE.PRQ NEE.PRR NEP NEE TLRD

90
Cheniere Energy Partners downgraded to neutral from overweight at J.P. Morgan

2018-05-15 marketwatch
Cheniere Energy (LNG) saw three upward target price revisions following its 1Q18 earnings. These changes could be due to an increase in its 2018 guidance.
TRP CQP CLMT LNG MS.PRE MS.PRF MS.PRG NEP MS.PRA MS.PRI MS.PRK NYLD CQH MS PLX NYLD.A

0
NextEra Energy Partners, LP 2018 Q1 - Results - Earnings Call Slides

2018-04-25 seekingalpha
The following slide deck was published by NextEra Energy Partners, LP in conjunction with their 2018 Q1 earnings call.
NEP

1
NextEra Energy Partners: Strong Q1 Performance Supports Continued Dividend Growth

2018-04-25 seekingalpha
Canadian assets to be sold to CPPIB at attractive pricing, with proceeds to be re-invested in higher yielding assets in US market.
NEE.PRI NEE.PRJ NEE.PRC NEE.PRQ NEE.PRR NEP NEE

5
NextEra Energy's (NEP) CEO Armando Pimentel on Q1 2018 Results - Earnings Call Transcript

2018-04-24 seekingalpha
Thank you, Brian. Good morning everyone and thank you for joining our First Quarter 2018 Combined Earnings Conference Call for NextEra Energy and NextEra Energy Partners.
NEE.PRI NEE.PRJ EQT NEE.PRC NEE.PRQ NEE.PRR NEP NEE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to NEP / NextEra Energy Partners LP on message board site Silicon Investor.

Neptune Technologies u0026 Bioressources Inc. - NTB.V Indications -- Lupus/Nephritis
The Neptune Society (NPTN) LCP (NYSE)- LOEWS CINEPLEX (LCX - TSE)
Zitel - Inept management or deliberate fraud? Stonepoint Group Ltd. SP - ASE
Are the UFOu0027s really the RETURN of the NEPHILIM? Loews Cineplex Entertainment (LCX) (was CPX)
CUSIP: 65341B106